发明授权
US3891761A N-Methyl-d-glucamine salt of 2(2-methyl-3{40 -trifluoro-methylanilino) nicotinic acid in the treatment of pain 失效
2(2-甲基-3 {40-三氟 - 甲基苯胺基)烟酸的N-甲基-d-葡糖胺盐治疗疼痛

  • 专利标题: N-Methyl-d-glucamine salt of 2(2-methyl-3{40 -trifluoro-methylanilino) nicotinic acid in the treatment of pain
  • 专利标题(中): 2(2-甲基-3 {40-三氟 - 甲基苯胺基)烟酸的N-甲基-d-葡糖胺盐治疗疼痛
  • 申请号: US45892074
    申请日: 1974-04-08
  • 公开(公告)号: US3891761A
    公开(公告)日: 1975-06-24
  • 发明人: SHERLOCK MARGARET H
  • 申请人: SCHERING CORP
  • 专利权人: Merck Sharp & Dohme Corp
  • 当前专利权人: Merck Sharp & Dohme Corp
  • 优先权: US45892074 1974-04-08; US34560873 1973-03-28
  • 主分类号: A61K27/00
  • IPC分类号: A61K27/00
N-Methyl-d-glucamine salt of 2(2-methyl-3{40 -trifluoro-methylanilino) nicotinic acid in the treatment of pain
摘要:
This invention relates to the N-methyl-D-glucamine salt of 2(2''-methyl-3''-trifluoromethylanilino) nicotinic acid and to its particular suitability as a parenterally administered analgesic agent.
信息查询
0/0